This may well turn out to be a dog and there’s no doubt that strategy from management has been incredibly poor and communication.... well, non-existent! The company has been run poorly but I can’t help but think that a product that improves UI to a point where surgery may not be required, should be every clinician’s first option prior to recommending surgery. Couple that with the knowledge that a strong pelvic floor improves POP cases and sexual pleasure and this product has everything a multinational should want. I mean if the essential oil market is worth $10 Billion, there’s definitely a market for Pericoach! I’m holding on for the ride.
- Forums
- ASX - By Stock
- Ann: PeriCoach CE Marking for Treatment of Pelvic Organ Prolapse
This may well turn out to be a dog and there’s no doubt that...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)